Literature DB >> 31146564

Correction of mildly dysplastic hips with periacetabular osteotomy demonstrates promising outcomes, achievement of correction goals, and excellent five-year survivorship.

A T Livermore1, L A Anderson1, M B Anderson1, J A Erickson1, C L Peters1.   

Abstract

AIMS: The aim of this study was to compare patient-reported outcome measures (PROMs), radiological measurements, and total hip arthroplasty (THA)-free survival in patients who underwent periacetabular osteotomy (PAO) for mild, moderate, or severe developmental dysplasia of the hip. PATIENTS AND METHODS: We performed a retrospective study involving 336 patients (420 hips) who underwent PAO by a single surgeon at an academic centre. After exclusions, 124 patients (149 hips) were included. The preoperative lateral centre-edge angle (LCEA) was used to classify the severity of dysplasia: 18° to 25° was considered mild (n = 20), 10° to 17° moderate (n = 66), and < 10° severe (n = 63). There was no difference in patient characteristics between the groups (all, p > 0.05). Pre- and postoperative radiological measurements were made. The National Institute of Health's Patient Reported Outcomes Measurement Information System (PROMIS) outcome measures (physical function computerized adaptive test (PF CAT), Global Physical and Mental Health Scores) were collected. Failure was defined as conversion to THA or PF CAT scores < 40, and was assessed with Kaplan-Meier analysis. The mean follow-up was five years (2 to 10) ending in either failure or the latest contact with the patient.
RESULTS: There was no significant difference in PROMs for moderate (p = 0.167) or severe (p = 0.708) groups compared with the mild dysplasia group. The numerical pain scores were between 2 and 3 units in all groups at the final follow-up (all, p > 0.05). There was no significant difference (all, p > 0.05) in the proportion of patients achieving target correction for the LCEA between groups. The mean correction was 12° in the mild, 15° in the moderate (p = 0.135), and 23° in the severe group (p < 0.001). Failure-free survival at five years was 100% for mild, 79% for moderate, and 92% for severely dysplastic hips (p = 0.225).
CONCLUSION: Although requiring less correction than hips with moderate or severe dysplasia, we found PAO for mild dysplasia to be associated with promising PROMs, consistent with that of the general United States population, and excellent survivorship at five years. Future studies should compare these results with the outcome after arthroscopy of the hip in patients with mild dysplasia. Cite this article: Bone Joint J 2019;101-B(6 Supple B):16-22.

Entities:  

Keywords:  Mild acetabular dysplasia; Patient-reportedoutcomes; Periacetabular osteotomy; Total hip arthroplasty-free survivorship

Mesh:

Year:  2019        PMID: 31146564     DOI: 10.1302/0301-620X.101B6.BJJ-2018-1487.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  5 in total

Review 1.  [Recent research progress of hip-preserving treatment for adolescents and adults with developmental dysplasia of the hip].

Authors:  Jinyan Wu; Xiaodong Chen
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-12-15

2.  Assessment of Disability Related to Hip Dysplasia Using Objective Measures of Physical Performance.

Authors:  Elizabeth J Scott; Michael C Willey; Arthur Mercado; John Davison; Jason M Wilken
Journal:  Orthop J Sports Med       Date:  2020-02-27

3.  Physical Performance Tests Correlate With Patient-reported Outcomes After Periacetabular Osteotomy: A Prospective Study.

Authors:  Elizabeth J Scott; Michael C Willey; John C Davison; Robert W Westermann; Amanda C Paulson; Jason M Wilken
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2021-06-08

4.  The association the patient-reported outcomes after periacetabular osteotomy with radiographic features: a short-term retrospective study.

Authors:  Yinuo Fan; Weifeng Li; Yunlong Wu; Ruoyu Li; Guoju Hong; Zhongfeng Li; Lixin Chen; Hanjun Fang; Chi Zhou; Wei He; Zhenqiu Chen
Journal:  J Orthop Surg Res       Date:  2021-12-19       Impact factor: 2.359

5.  External Validation of the FEAR Index in Borderline Acetabular Dysplasia.

Authors:  Maria T Schwabe; John C Clohisy; Elizabeth A Graesser; Cecilia Pascual-Garrido; Jeffrey J Nepple
Journal:  Orthop J Sports Med       Date:  2022-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.